{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T07:31:07Z","timestamp":1788939067211,"version":"build-2803163510"},"reference-count":6,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T00:00:00Z","timestamp":1767830400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/deed.de"},{"start":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T00:00:00Z","timestamp":1767830400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/deed.de"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Anaesthesiologie"],"DOI":"10.1007\/s00101-025-01639-x","type":"journal-article","created":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T10:42:24Z","timestamp":1767868944000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Anesthetic diversity: a pillar of healthcare system resilience and a strategic imperative in an era of uncertainty","Vielfalt der An\u00e4sthetika \u2013 eine tragende S\u00e4ule f\u00fcr ein resilientes Gesundheitssystem und eine strategische Notwendigkeit in einer \u00c4ra multipler Unsicherheiten"],"prefix":"10.1007","author":[{"given":"Peter","family":"Kranke","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Kleinberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Meybohm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beverly K.","family":"Philip","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurentiu","family":"Marin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Zacharowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,8]]},"reference":[{"key":"1639_CR1","unstructured":"Thomas K (2017) A\u00a0Vital Drug Runs Low, Though Its Base Ingredient Is in Many Kitchens. N\u00a0Y Times"},{"key":"1639_CR2","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.1213\/ANE.0000000000003405","volume":"127","author":"I Kissin","year":"2018","unstructured":"Kissin\u00a0I, Vlassakov\u00a0K (2018) Pharmacological Basis of Anesthesia: How to Overcome Stagnation? Anesth Analg 127:1268\u20131270","journal-title":"Anesth Analg"},{"key":"1639_CR3","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1213\/ANE.0000000000007378","volume":"141","author":"L Marin","year":"2025","unstructured":"Marin\u00a0L, Kleinberg\u00a0RL (2025) Climate Change, Emissions of Volatile Anesthetics, and Policy Making: The Case of Desflurane. Anesth Analg 141:123\u2013127","journal-title":"Anesth Analg"},{"key":"1639_CR4","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1111\/anae.16189","volume":"79","author":"JM Slingo","year":"2024","unstructured":"Slingo\u00a0JM, Slingo\u00a0ME (2024) The science of climate change and the effect of anaesthetic gas emissions. Anaesthesia 79:252\u2013260","journal-title":"Anaesthesia"},{"key":"1639_CR5","doi-asserted-by":"publisher","first-page":"111210","DOI":"10.1016\/j.jclinane.2023.111210","volume":"90","author":"F Dexter","year":"2023","unstructured":"Dexter\u00a0F, Hindman\u00a0BJ (2023) Systematic review with meta-analysis of relative risk of prolonged times to tracheal extubation with desflurane versus sevoflurane or isoflurane. J\u00a0Clin Anesth 90:111210. https:\/\/doi.org\/10.1016\/j.jclinane.2023.111210","journal-title":"J Clin Anesth"},{"key":"1639_CR6","doi-asserted-by":"publisher","first-page":"e227","DOI":"10.1016\/S2542-5196(25)00027-0","volume":"9","author":"A Talbot","year":"2025","unstructured":"Talbot\u00a0A, Holl\u00e4nder\u00a0HC, Bentzer\u00a0P (2025) Greenhouse gas impact from medical emissions of halogenated anaesthetic agents: a\u00a0sales-based estimate. Lancet Planet Health 9:e227\u201335","journal-title":"Lancet Planet Health"}],"container-title":["Die Anaesthesiologie"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00101-025-01639-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00101-025-01639-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00101-025-01639-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T10:42:27Z","timestamp":1767868947000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00101-025-01639-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,8]]},"references-count":6,"alternative-id":["1639"],"URL":"https:\/\/doi.org\/10.1007\/s00101-025-01639-x","relation":{},"ISSN":["2731-6858","2731-6866"],"issn-type":[{"value":"2731-6858","type":"print"},{"value":"2731-6866","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,8]]},"assertion":[{"value":"29 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"P.\u00a0Kranke received consultation fees from TEVA Ratiopharm, Sintetica, Baxter, Amicus Clinical Development, BBraun. P.\u202fK.\u00a0has received compensation to give lectures and perform educational activities for Fresenius Kabi, CSL Vifor, Senzyme, CSL Behring, Pharmacosmos, Baxter, Pajunk, Gruenenthal, Livanova. P.\u00a0Meybohm received honoraria for scientific lectures from CSL Behring GmbH, Pharmacosmos GmbH, and CSL Vifor GmbH. B.K.\u00a0Philip received consultancy honoraria from Haisco-US. L.\u00a0Marin: Between 2022 and 2023 received speakers and consultancy honoraria from Baxter. Since 2023. LM has declined any further financial, travel-related, or other forms of direct or indirect compensation from Baxter. K.\u00a0Zacharowski: The Department of Anaesthesiology, Intensive Care Medicine and Pain Therapy of the University Hospital Frankfurt, Goethe University received support from B.\u00a0Braun Melsungen, Melsungen (Germany), CSL Behring, Hattersheim (Germany), Fresenius Kabi, Bad Homburg (Germany), and Vifor Pharma, Munich (Germany) for the implementation of Frankfurt\u2018s Patient Blood Management program. KZ has received honoraria for participation in advisory board meetings for Haemonetics, Boston (USA) and Vifor, Munich (Germany) and received speaker fees from CSL Behring, Hattersheim (Germany), Masimo, Irvine (USA), Pharmacosmos, Copenhagen (Denmark), Boston Scientific, D\u00fcsseldorf (Germany), Salus, Bruckm\u00fchl (Germany), iSEP, Nantes (France), Edwards, Munich (Germany), Hemosonics, Asni\u00e8res-sur-Seine (France) and GE Healthcare, D\u00fcsseldorf (Germany). He is the principal investigator of the EU-Horizon 2020 project ENVISION (Intelligent plug-and-play digital tool for real-time surveillance of COVID-19 patients and smart decision-making in intensive care units) and Horizon Europe 2021 project COVend (Biomarker and AI-supported FX06 therapy to prevent progression from mild and moderate to severe stages of COVID-19). Partner for EU Horizon 2023 project EDiHTA. KZ leads as CEO the Christoph Lohfert Foundation, Hamburg (Germany) as well as the Health, Patient Safety & PBM Foundation, Bad Homburg (Germany). R.\u00a0Kleinberg declares no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"For this article no studies with human participants or animals were performed by any of the authors. All studies mentioned were in accordance with the ethical standards indicated in each case.The supplement containing this article is not sponsored by industry.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical standards"}}]}}